Question

the differences between the spectra. Comment on the isotope patterns that you expect to see for each peak Probl peaks at m: 181 (100%), 182 (4.5 %). and 184 (3.4s) were observed. The (see Appendix 5) spectrum revealed peaks at mz 415 (6.4%), 417 (100%), 418 (13.1% ) , 419 (10.2 %), 421 (30.1%), 422 (3.9%) am Relative intensities (%) for different ratios AgNO3 : PPh (a) Account for the results, statin 1:1, 1:2 spectrum was recorded in positive negative mode. (b) Draw the struct present in [MeSbl[Ph,SbCll. Do ions possess isomers? If so, spectrometric data provide inform. isomer or isomers are presen m/z 1:3 1:4 42 32 369 0 100 89 410 0 0 20 100 633 100 100 Appendix 5.) [Data: HJ. Breun J. Organomet. Chem., vol. 695, 17 11 2 0 802 22 22 1 1.0 mmol of the ligand, L, show with 0.50 mmol of PCl MALDI-TOF mass spectrum c was run in a-cyano-4-hydroxy The most intense peaks in the 893 2 4 1064 [Data: L.S. Bonnington et al. (1999) Inorg. Chim. Acta, vol. 290, p. 213. mass spectrum were mz 8* 302.1. Assign these peaks an the product that is consisten 4.14 The ESI mass spectrum (positive mode) of the ligand shown below exhibits two peaks at m/z 299.2 (base peak) and 321.1. (a) What is a 'base peak'? (b) Suggest how the observed peaks arise. [Data: C.J. Sumby et al. (2009) Tetrahedron, vol. 65, p. 4681.] N Data: L. Szüčová et P. 2710.] helow contained a peak envelope with m/z 529.9 (46%), 530.9 The ESI mass spectrum (positive mode) of the complex IS 4.18 In the MALDI-TOF thown bele

Answer 1

a) The molecular weight of the given structure is matching with base peak containing mass m/z 299.2.9.

The given structure is named as 2-(N-propylamido)-6-(N-(methypyridinyl)amido)pyridine.